Onset of high blood pressure might be possible after the start of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis.
How ivacaftor changes inflammation and protein levels in the bloodstream of people with CF and the G551D mutation
Features of Salt Imbalance and Pseudo Barter Syndrome in hospitalized Children and Young Adults with Cystic Fibrosis.
Development and electronic validation of the revised Cystic Fibrosis Questionnaire (CFQ-R Teen/Adult): New tool for monitoring psychosocial health in CF.
CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation
